Alterations in relaxation to lactate and H2O2 in human placental vessels from gestational diabetic pregnancies

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 278, Issue 3 47-3, 2000, Pages

  Figueroa, Reinaldo ^a   Martinez, Edilberto ^a   Fayngersh, Raisa P ^a   Tejani, Nergesh ^a   Mohazzab H, Kamal M ^a   Wolin, Michael S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Fetal circulation; Oxidant signaling; Redox signaling

Indexed keywords

ARACHIDONIC ACID; CATALASE; FORSKOLIN; GLYCERYL TRINITRATE; HYDROGEN PEROXIDE; INDOMETACIN; LACTIC ACID; NITRIC OXIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FETUS; FETUS CIRCULATION; HUMAN; OXIDATION REDUCTION REACTION; PLACENTA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0034063055     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2000.278.3.h706     Document Type: Article

References (25)

1. Burke, T. M., and M. S. Wolin. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. Am. J. Physiol. Heart Circ. Physiol. 252: H721-H732, 1987.
2. Carpenter, M. W., and D. R. Coustan. Criteria for screening tests for gestational diabetes. Am. J. Obstet. Gynecol. 144: 768-773, 1982.
3. Chaudhuri, G., G. M. Buga, M. E. Gold, K. S. Wood, and L. J. Ignarro. Characterization and actions of human umbilical endothelium-derived relaxing factor. Br. J. Pharmacol. 102: 331-336, 1991.
4. Chen, Y.-L., M. S. Wolin, and E. J. Messina. Evidence for a cGMP mediation of skeletal muscle arteriolar dilation to lactate. J. Appl. Physiol. 81: 349-354, 1996.
5. Figueroa, R., E. Martinez, R. P. Fayngersh, H. Jiang, H. A. Omar, N. Tejani, and M. S. Wolin. Absence of relaxation to lactate in human placental vessels of pregnancies with severe preeclampsia. Am. J. Obstet. Gynecol. 173: 1800-1806, 1995.
6. Figueroa, R., H. A. Omar, N. Tejani, and M. S. Wolin. Gestational diabetes alters human placental vascular responses to changes in oxygen tension. Am. J. Obstet. Gynecol. 168: 1616-1622, 1993.
7. Harder, D. R., W. B. Campbell, and R. J. Roman. Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J. Vasc. Res. 32: 79-92, 1995.
8. Hemler, M. E., H. W. Cook, and W. E. Lands. Prostaglandin biosynthesis can be triggered by lipid peroxides. Arch. Biochem. Biophys. 193: 340-345, 1979.
9. Hollingsworth, D. R. Diabetes. In: Medical Counseling Before Pregnancy, edited by D. B. Hollingsworth and R. Resnik. New York: Churchill Livingstone, 1988, p. 274.
10. Ignarro, L. J. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ. Res. 65: 1-21, 1989.
11. Lyall, F., A. Young, and I. A. Greer. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am. J. Obstet. Gynecol. 173: 714-718, 1995.
12. 2. Am. J. Physiol. Heart Circ. Physiol. 276: H235-H241, 1999.
13. 2-associated relaxation. Am. J. Physiol. Heart Circ. Physiol. 271: H1900-H1906, 1996.
14. 2 sensor. Am. J. Physiol. Lung Cell. Mol. Physiol. 267: L23-L831, 1994.
15. Myatt, L., R. B. Rosenfeld, A. L. W. Eis, D. E. Brockman, I. Greer, and F. Lyall. Nitrotyrosine residues in placenta: evidence of peroxynitrite formation and action. Hypertension 28: 488-493, 1996.
16. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039-1057, 1979.
17. Omar, H. A., R. Figueroa, R. A. Omar, N. Tejani, and M. S. Wolin. Hydrogen peroxide and reoxygenation cause prostaglandin-mediated contraction of human placental arteries and veins. Am. J. Obstet. Gynecol. 167: 201-207, 1992.
18. Omar, H. A., R. Figueroa, R. A. Omar, and M. S. Wolin. Properties of an endogenous arachidonic acid-elicited relaxing mechanism in human placental vessels. Am. J. Obstet. Gynecol. 167: 1064-1070, 1992.
19. Omar, H. A., R. Figueroa, N. Tejani, and M. S. Wolin. Properties of a lactate-induced relaxation in human placental arteries and veins. Am. J. Obstet. Gynecol. 169: 912-918, 1993.
20. 2 and cGMP. Am. J. Physiol. Lung Cell. Mol. Physiol. 264: L141-L145, 1993.
21. Seaman, K. B., and J. W. Daly. Forskolin: its biological and chemical properties. Adv. Cyclic Nucleotide Protein Phosphorylation Res. 20: 1-150, 1986.
22. Van de Voorde, J., H. Vanderstichele, and I. Levsen. Release of endothelium-derived relaxing factor from human umbilical vessels. Circ. Res. 60: 517-522, 1987.
23. Walsh, S. W., and V. M. Parisi. The role of prostanoids and thromboxane in the regulation of placental blood flow. In: Reproductive and Perinatal Medicine: The Uterine Circulation, edited by C. R. Rosenfield. Ithaca, NY: Perinatology, 1989, vol. 10, p. 273-298.
24. Wolin, M. S., C. A. Davidson, P. M. Kaminski, R. P. Fayngersh, and K. M. Mohazzab-H. Oxidant-nitric oxide signalling mechanisms in vascular tissue. Biochemistry (Mosc.) 63: 810-816, 1998.
25. Zhang, X., Y.-W. Xie, A. Nasjletti, X. Xu, M. S. Wolin, and T. H. Hintze. ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation 95: 176-182, 1997.